Literature DB >> 23942834

Recent developments in manufacturing oligosaccharides with prebiotic functions.

Zoltán Kovács1, Eric Benjamins, Konrad Grau, Amad Ur Rehman, Mehrdad Ebrahimi, Peter Czermak.   

Abstract

The market for prebiotics is steadily growing. To satisfy this increasing worldwide demand, the introduction of effective bioprocessing methods and implementation strategies is required. In this chapter, we review recent developments in the manufacture of galactooligosaccharides (GOS) and fructooligosaccharides (FOS). These well-established oligosaccharides (OS) provide several health benefits and have excellent technological properties that make their use as food ingredients especially attractive. The biosyntheses of lactose-based GOS and sucrose-based FOS show similarities in terms of reaction mechanisms and product formation. Both GOS and FOS can be synthesized using whole cells or (partially) purified enzymes in immobilized or free forms. The biocatalysis results in a final product that consists of OS, unreacted disaccharides, and monosaccharides. This incomplete conversion poses a challenge to manufacturers because an enrichment of OS in this mixture adds value to the product. For removing digestible carbohydrates from OS, a variety of bioengineering techniques have been investigated, including downstream separation technologies, additional bioconversion steps applying enzymes, and selective fermentation strategies. This chapter summarizes the state-of-the-art manufacturing strategies and recent advances in bioprocessing technologies that can lead to new possibilities for manufacturing and purifying sucrose-based FOS and lactose-based GOS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23942834     DOI: 10.1007/10_2013_237

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  7 in total

Review 1.  Synthesis and purification of galacto-oligosaccharides: state of the art.

Authors:  Carlos Vera; Andrés Córdova; Carla Aburto; Cecilia Guerrero; Sebastián Suárez; Andrés Illanes
Journal:  World J Microbiol Biotechnol       Date:  2016-10-18       Impact factor: 3.312

2.  Facile, high quality sequencing of bacterial genomes from small amounts of DNA.

Authors:  Momchilo Vuyisich; Ayesha Arefin; Karen Davenport; Shihai Feng; Cheryl Gleasner; Kim McMurry; Beverly Parson-Quintana; Jennifer Price; Matthew Scholz; Patrick Chain
Journal:  Int J Genomics       Date:  2014-11-13       Impact factor: 2.326

Review 3.  A nutritional approach to microbiota in Parkinson's disease.

Authors:  Gizem Özata Uyar; Hilal Yildiran
Journal:  Biosci Microbiota Food Health       Date:  2019-06-29

4.  Purification of Crude Fructo-Oligosaccharide Preparations Using Probiotic Bacteria for the Selective Fermentation of Monosaccharide Byproducts.

Authors:  Rong Fan; Jan Philipp Burghardt; Jinqing Huang; Tao Xiong; Peter Czermak
Journal:  Front Microbiol       Date:  2021-01-26       Impact factor: 5.640

Review 5.  Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).

Authors:  Qingchun Lei; Tingting Wu; Jin Wu; Xiaogang Hu; Yingxia Guan; Ying Wang; Jinyuan Yan; Guolin Shi
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

Review 6.  Recent developments in microbial production of high-purity galacto-oligosaccharides.

Authors:  Anna Maráz; Zoltán Kovács; Eric Benjamins; Melinda Pázmándi
Journal:  World J Microbiol Biotechnol       Date:  2022-04-20       Impact factor: 4.253

Review 7.  Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.

Authors:  Margherita Alfonsetti; Vanessa Castelli; Michele d'Angelo
Journal:  Nutrients       Date:  2022-01-17       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.